Cardiac sequelae in athletes following COVID-19 vaccination: evidence and misinformation
- 10 August 2023
- journal article
- editorial
- Published by BMJ in British Journal of Sports Medicine
- Vol. 57 (21) , 1400-1402
Abstract
The recognition of myocarditis as a rare side effect of SARS-CoV-2 mRNA vaccination has sparked a global debate on vaccine safety, especially in the realm of sports. The main proposed mechanisms in the pathogenesis of COVID-19 mRNA vaccination-associated myocarditis (C-VAM) are based on the activation of the innate- and adaptive immune system against a susceptible immune-genetic background, including the recognition of mRNA as an antigen by the immune system, molecular mimicry between SARS-CoV-2 spike glycoprotein and cardiac tissue antigens and inflammatory sex-hormone signalling. The relatively younger age of the athlete population hypothetically constellates an increased risk of C-VAM. A subgroup analysis in individuals under 40 years revealed a low incidence of myocarditis following COVID-19 mRNA vaccination when compared to positive SARS-CoV-2 tests. No confirmed cases of athletes experiencing cardiac complications after mRNA vaccination have been reported. Most athletes only reported mild side effects after COVID-19 vaccination. A small but statistically significant decrease in maximal oxygen consumption in recreational athletes occurred after BNT162b2 mRNA booster vaccine administration. The clinical relevance and temporality of which remain to be determined. Many speculative social media reports attribute sudden cardiac arrest/death (SCA/D) in athletes to mRNA vaccination. Large media outlets have thoroughly debunked these claims. There is currently no evidence to support the claim that COVID-19 mRNA vaccination increases the risk of myocardial sequelae or SCA/D in athletes. However, specific vaccine regimen selection and timing may be appropriate to prevent detrimental performance effects.Keywords
This publication has 8 references indexed in Scilit:
- No Association Between Out-of-Hospital Cardiac Arrest and COVID-19 VaccinationCirculation, 2023
- Effect of BNT162b2 mRNA booster vaccination on VO2max in recreational athletes: A prospective cohort studyHealth Science Reports, 2022
- Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infectionNature Medicine, 2021
- Tolerability and impact of SARS-CoV-2 vaccination in elite athletesThe Lancet Respiratory Medicine, 2021
- Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanismsNature Reviews Cardiology, 2021
- Relationship between inflammatory biomarkers and testosterone levels in male master athletes and non-athletesExperimental Gerontology, 2021
- Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control studyBMJ, 2021
- Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseasesClinical Immunology, 2020